… In summary, β-blocker treatment in patients with HFrEF invariably reduced mortality and
HF hospitalization within 1 year of starting treatment on top of standard treatment (Table 1). …

… in these studies was well tolerated and in addition to improved mortality, β-blocker therapy
… Initiation of β-blocker therapy in heart failure may be associated with deterioration of cardiac …

… of β-blocker therapy may extend beyond observations described in this report and include
benefits to regulation of ventilation during sleep. Furthermore, we speculate that any β-…

… The increased effectiveness of β-blocker therapy for DD … -blocker therapy status, the absence
of β-blocker randomization … the effect of β-blocker therapy on survival can and should be …

… This analysis suggests that for patients with heart failure in sinus rhythm, the effect of beta-blockers
on mortality in patients with LVEF 40–49% is similar to that observed with LVEF < 40…

… concentrations and response to β blocker therapy. During a mean of 10 months of follow-up,
we found uptitration to higher doses of β-adrenergic blockers was associated with better …

… basis for this revolution in heart failure therapy. This article reviews these … blocker therapy
on sudden death in patients with heart failure. The role of the adrenergic system in heart failure …

… As a result, our findings reveal that β blocker treatment added to conventional treatment in
patients with heart failure caused a decrease in LA diameter and volume without changing LA …

… in New York Heart Association (NYHA) class II to IV heart failure … of β-blocker therapy in
chronic heart failure; the -blocker therapy in chronic heart failure; the US Carvedilol heart failure …

… the pathophysiology and treatment of this disease. This … heart failure based on the
pathophysiology of the disease. Systolic heart failure is characterized by a decrease in left ventricular …